Search results: (10000)
News Biosimilars in the Prophylaxis of Venous Thromboembolism
Hospitalized patients with internal diseases or after surgery have an increased risk of venous thromboembolism (VTE). The first-line prophylaxis for patients at high risk of thrombosis with an acceptable risk of bleeding is anticoagulants from the low molecular weight heparin (LMWH) group.